Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2021 Dec;74(12):1120-1122.
doi: 10.1016/j.rec.2021.07.005. Epub 2021 Jul 16.

Pericarditis after administration of the BNT162b2 mRNA COVID-19 vaccine

[Article in English, Spanish]
Almudena Ramírez-García  1 , Sara Lozano Jiménez  2 , Ignacio Darnaude Ximénez  3 , Alberto Gil Cacho  4 , Ramón Aguado-Noya  4 , Javier Segovia Cubero  2
Affiliations
Case Reports

Pericarditis after administration of the BNT162b2 mRNA COVID-19 vaccine

[Article in English, Spanish]
Almudena Ramírez-García et al. Rev Esp Cardiol (Engl Ed). 2021 Dec.
No abstract available

PubMed Disclaimer

Figures

Figure 1
Figure 1
A: electrocardiogram obtained in the emergency department. Sinus tachycardia at 105 bpm, normal axis (90°). Normal PR interval (120 ms). Narrow QRS. Nonsignificant Q wave in the inferior wall. Without acute repolarization abnormalities. Corrected QT in the normal range. B: electrocardiogram obtained 2 days later in the cardiology clinic. Sinus rhythm at 75 bpm, normal axis. Normal PR interval (120 ms), with a PR segment decrease. Narrow QRS. Concave and generalized ST-segment elevation. Corrected QT in the normal range.
Figure 2
Figure 2
A: electrocardiogram obtained in the emergency department showing sinus rhythm at 75 bpm. Normal axis. Narrow QRS and ST-segment elevation in the inferolateral wall. Corrected QT in the normal range. B: electrocardiogram obtained 5 days later showing sinus rhythm at 85 bpm. Normal axis. Narrow QRS. Generalized ST-segment elevation with concave morphology. Corrected QT in the normal range.
See this image and copyright information in PMC

Comment on

  • Acute myocarditis after administration of the BNT162b2 vaccine against COVID-19.
    Bautista García J, Peña Ortega P, Bonilla Fernández JA, Cárdenes León A, Ramírez Burgos L, Caballero Dorta E. Bautista García J, et al. Rev Esp Cardiol (Engl Ed). 2021 Sep;74(9):812-814. doi: 10.1016/j.rec.2021.04.005. Epub 2021 Apr 27. Rev Esp Cardiol (Engl Ed). 2021. PMID: 33994339 Free PMC article. No abstract available.

References

    1. García J.B., Ortega P.P., Antonio Bonilla Fernández J., León A.C., Burgos L.R., Dorta E.C. Miocarditis aguda tras administración de vacuna BNT162b2 contra la COVID-19. Rev Esp Cardiol. 2021 doi: 10.1016/j.recesp.2021.03.009. - DOI - PMC - PubMed
    1. Law B., Sturkenboom M. D2.3 Priority List of Adverse Events of Special Interest: COVID-19. Brighton Collaboration. 2020 Disponible en: https://brightoncollaboration.us/wp-content/uploads/2020/06/SPEAC_D2.3_V.... Consultado 15 May 2021.
    1. Diaz-Arocutipa C., Saucedo-Chinchay J., Imazio M. Pericarditis in patients with coronavirus disease 2019: a systematic review. J Cardiovasc Med (Hagerstown). 2021 doi: 10.2459/JCM.0000000000001202. - DOI - PubMed
    1. Talotta R. Do COVID-19 RNA-based vaccines put at risk of immune-mediated diseases? In reply to “Potential antigenic cross-reactivity between SARS-CoV-2 and human tissue with a possible link to an increase in autoimmune diseases”. Clin Immunol. 2021;224:108665. - PMC - PubMed
    1. Esteban Calvo C., Gil López-Oliva A., Ibáñez Ruiz C. RAM. Reacciones adversas a medicamentos. Boletín Informativo del Centro de Farmacovigilancia de la Comunidad de Madrid. 2021;28(1.) Disponible en: http://www.madrid.org/bvirtual/BVCM050298.pdf. Consultado 15 May 2021.